Karyopharm Therapeutics Inc. (KPTI) stock
KPTINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTIQ
$0.04−0.01 (-20.00%)
Close on Nov 9, 2026Market cap $1.16KP/E –Yield –
Karyopharm Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Karyopharm Therapeutics's price to book ratio was 13.7× on Apr 30, 2021, against 29.0× a year earlier. Over the last 5 years it ranged from 1.4× to 29.0×, with a median of 4.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Apr 30, 2021 | 13.7× | +0.1 |
| 2020 | Dec 31, 2020 | 13.6× | −6.5 |
| 2019 | Dec 31, 2019 | 20.1× | +16.8 |
| 2018 | Dec 31, 2018 | 3.3× | +0.1 |
| 2017 | Dec 29, 2017 | 3.2× | +1.0 |
| 2016 | Dec 30, 2016 | 2.2× | +0.1 |
| 2015 | Dec 31, 2015 | 2.1× | −3.2 |
| 2014 | Dec 31, 2014 | 5.4× | – |
See a number that looks wrong?